These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21985408)

  • 1. Bioanalysis in drug discovery.
    Hill H
    Bioanalysis; 2011 Oct; 3(19):2155-8. PubMed ID: 21985408
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategies at the interface of drug discovery and development: early optimization of the solid state phase and preclinical toxicology formulation for potential drug candidates.
    Palucki M; Higgins JD; Kwong E; Templeton AC
    J Med Chem; 2010 Aug; 53(16):5897-905. PubMed ID: 20527889
    [No Abstract]   [Full Text] [Related]  

  • 3. Meeting the demands of regulatory requirements: the significance of ADME.
    Guttendorf R
    Bioanalysis; 2012 Jun; 4(12):1395-7. PubMed ID: 22793021
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the assessment of effects of food on the pharmacokinetics of drugs in early development.
    Li Z; Vachharajani NN; Krishna R
    Biopharm Drug Dispos; 2002 May; 23(4):165-71. PubMed ID: 12015791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on ion channel transporters as a target for the drug discovery].
    Imaizumi Y; Kaneko S
    Nihon Yakurigaku Zasshi; 2011 Dec; 138(6):227. PubMed ID: 22303567
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytochrome P450 metabolism and inhibition: analysis for drug discovery.
    Jones BC; Middleton DS; Youdim K
    Prog Med Chem; 2009; 47():239-63. PubMed ID: 19328293
    [No Abstract]   [Full Text] [Related]  

  • 8. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
    Crivori P; Poggesi I
    Eur J Med Chem; 2006 Jul; 41(7):795-808. PubMed ID: 16644065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from candidate drug attrition.
    Empfield JR; Leeson PD
    IDrugs; 2010 Dec; 13(12):869-73. PubMed ID: 21154145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioengineering. Lung-on-a-chip breathes new life into drug discovery.
    Service RF
    Science; 2012 Nov; 338(6108):731. PubMed ID: 23139305
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG; Bolt HM
    Arch Toxicol; 2008 Oct; 82(10):665-6. PubMed ID: 18751968
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro models for in vivo drug profiles.
    Kling J
    Nat Biotechnol; 1996 Dec; 14(13):1655-6. PubMed ID: 9634846
    [No Abstract]   [Full Text] [Related]  

  • 14. High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures.
    Korfmacher W
    Bioanalysis; 2011 Jun; 3(11):1169-71. PubMed ID: 21649491
    [No Abstract]   [Full Text] [Related]  

  • 15. Discovering drugs through biological transformation: role of pharmacologically active metabolites in drug discovery.
    Fura A; Shu YZ; Zhu M; Hanson RL; Roongta V; Humphreys WG
    J Med Chem; 2004 Aug; 47(18):4339-51. PubMed ID: 15317447
    [No Abstract]   [Full Text] [Related]  

  • 16. Improved preclinical safety assessment using micro-BAL devices: the potential impact on human discovery and drug attrition.
    Giri S; Bader A
    Drug Discov Today; 2011 May; 16(9-10):382-97. PubMed ID: 21354326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of human embryonic stem cells in drug discovery. Counterpoint.
    Esteso P; Gearhart JD
    Clin Pharmacol Ther; 2011 May; 89(5):641-3. PubMed ID: 21512522
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategies for conducting ADME studies during lead generation in the drug discovery process.
    Cramer JW; Mattioni BE; Savin KA
    IDrugs; 2010 Dec; 13(12):857-61. PubMed ID: 21154143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug discovery using small teleost fish].
    Taniguchi Y; Yoshioka N
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():413-7. PubMed ID: 23513876
    [No Abstract]   [Full Text] [Related]  

  • 20. Christian K. Schneider. Interview by Bethan Hughes.
    Schneider CK
    Nat Rev Drug Discov; 2009 Apr; 8(4):270. PubMed ID: 19337268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.